Individualized Dose Prescription for Hypofractionation in Advanced Non-Small-Cell Lung Cancer Radiotherapy: An in silico TrialHOFFMANN, Aswin L; TROOST, Esther G. C; HUIZENGA, Henk et al.International journal of radiation oncology, biology, physics. 2012, Vol 83, Num 5, pp 1596-1602, issn 0360-3016, 7 p.Article

Targeting Hypoxia, HIF-1, and Tumor Glucose Metabolism to Improve Radiotherapy Efficacy : Reinventing Cancer Cell MetabolismMEIJER, Tineke W. H; KAANDERS, Johannes H. A. M; SPAN, Paul N et al.Clinical cancer research (Print). 2012, Vol 18, Num 20, pp 5585-5594, issn 1078-0432, 10 p.Article

Improving chemoradiation efficacy by PI3-K/AKT inhibitionSTEGEMAN, Hanneke; SPAN, Paul N; KAANDERS, Johannes H. A. M et al.Cancer treatment reviews. 2014, Vol 40, Num 10, pp 1182-1191, issn 0305-7372, 10 p.Article

Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: Spatial distribution and prognostic value of GLUT1 and MCT4MEIJER, Tineke W. H; SCHUURBIERS, Olga C. J; BUSSINK, Johan et al.Lung cancer. 2012, Vol 76, Num 3, pp 316-323, issn 0169-5002, 8 p.Article

Hypoxic Regulation and Prognostic Value of LAMP3 Expression in Breast CancerNAGELKERKE, Anika; MUJCIC, Hilda; BUSSINK, Johan et al.Cancer. 2011, Vol 117, Num 16, pp 3670-3681, issn 0008-543X, 12 p.Article

Aerobic glycolysis in cancers : Implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxiaBUSK, Morten; HORSMAN, Michael R; KRISTJANSEN, Paul E. G et al.International journal of cancer. 2008, Vol 122, Num 12, pp 2726-2734, issn 0020-7136, 9 p.Article

Expression of EGFR Under Tumor Hypoxia: Identification of a Subpopulation of Tumor Cells Responsible for Aggressiveness and Treatment ResistanceHOOGSTEEN, Use J; MARRES, Henri A. M; DEN HOOGEN, Franciscus J. A. Van et al.International journal of radiation oncology, biology, physics. 2012, Vol 84, Num 3, pp 807-814, issn 0360-3016, 8 p.Article

Combretastatin A-4 Phosphate Affects Tumor Vessel Volume and Size Distribution as Assessed Using MRI-Based Vessel Size ImagingNIELSEN, Thomas; BENTZEN, Lise; PEDERSEN, Michael et al.Clinical cancer research (Print). 2012, Vol 18, Num 23, pp 6469-6477, issn 1078-0432, 9 p.Article

Tumor microenvironment in head and neck squamous cell carcinomas: Predictive value and clinical relevance of hypoxic markers. A reviewHOOGSTEEN, Ilse J; MARRES, Henri A. M; BUSSINK, Johan et al.Head & neck. 2007, Vol 29, Num 6, pp 591-604, issn 1043-3074, 14 p.Article

Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancerKAANDERS, Johannes H. A. M; WIJFFELS, Karien I. E. M; MARRES, Henri A. M et al.Cancer research (Baltimore). 2002, Vol 62, Num 23, pp 7066-7074, issn 0008-5472, 9 p.Article

Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trialNIJKAMP, Monique M; SPAN, Paul N; TERHAARD, Christiaan H. J et al.European journal of cancer (1990). 2013, Vol 49, Num 15, pp 3202-3209, issn 0959-8049, 8 p.Article

Radiolabeled cetuximab: dose optimization for epidermal growth factor receptor imaging in a head-and-neck squamous cell carcinoma modelHOEBEN, Bianca A. W; MOLKENBOER-KUENEN, Janneke D. M; OYEN, Wim J. G et al.International journal of cancer (Print). 2011, Vol 129, Num 4, pp 870-878, issn 0020-7136, 9 p.Article

Augmentation of Radiation Response by Motesanib, a Multikinase Inhibitor that Targets Vascular Endothelial Growth Factor ReceptorsKRUSER, Tim J; WHEELER, Deric L; ARMSTRONG, Eric A et al.Clinical cancer research (Print). 2010, Vol 16, Num 14, pp 3639-3647, issn 1078-0432, 9 p.Article

Patterns of proliferation related to vasculature in human head-and-neck carcinomas before and after transplantation in nude miceWIJFFELS, Karien I. E. M; KAANDERS, Johannes H. A. M; MARRES, Henri A. M et al.International journal of radiation oncology, biology, physics. 2001, Vol 51, Num 5, pp 1346-1353, issn 0360-3016Article

Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal CancerJANSSENS, Geert O; RADEMAKERS, Saskia E; BUSSINK, Johan et al.Clinical cancer research (Print). 2014, Vol 20, Num 5, pp 1345-1354, issn 1078-0432, 10 p.Article

Identification of residual metabolic-active areas within NSCLC tumours using a pre-radiotherapy FDG-PET-CT scan: A prospective validationAERTS, Hugo J. W. L; BUSSINK, Johan; OYEN, Wim J. G et al.Lung cancer. 2012, Vol 75, Num 1, pp 73-76, issn 0169-5002, 4 p.Article

Interleukin-12 has no effect on vascular density, perfusion, hypoxia and proliferation of an implanted human squamous cell carcinoma xenograft tumour despite up-regulation of ICAM-1VAN HERPEN, Carla M. L; BUSSINK, Johan; VAN DER KOGEL, Albert J et al.Anticancer research. 2005, Vol 25, Num 2A, pp 1015-1021, issn 0250-7005, 7 p.Article

Effects of nicotinamide and carbogen in different murine colon carcinomas: Immunohistochemical analysis of vascular architecture and microenvironmental parametersVAN LAARHOVEN, Hanneke W. M; BUSSINK, Johan; LOK, Jasper et al.International journal of radiation oncology, biology, physics. 2004, Vol 60, Num 1, pp 310-321, issn 0360-3016, 12 p.Article

Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomasLJUNGKVIST, Anna S. E; BUSSINK, Johan; RIJKEN, Paulus F. J. W et al.International journal of radiation oncology, biology, physics. 2002, Vol 54, Num 1, pp 215-228, issn 0360-3016Article

Changes in tumor hypoxia measured with A double hypoxic marker techniqueLJUNGKVIST, Anna S. E; BUSSINK, Johan; RIJKEN, Paulus F. J. W et al.International journal of radiation oncology, biology, physics. 2000, Vol 48, Num 5, pp 1529-1538, issn 0360-3016Article